{"title":"Animal experiment on osseointegration of porous titanium root analogue implants with composite CSn-TAK242 coating.","authors":"Hui Li, Dan Luo, Yudong Gao, Dashan Wang, Jianjun Yang, Zexian Xu","doi":"10.3389/fbioe.2025.1673758","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Chitosan nanoparticles loaded with TLR4 inhibitors (TAK242) were coated on porous titanium root analogue implants and placeded into beagles to investigate the role of TLR4 inhibitors in inhibiting inflammatory reactions and promoting osseointegration <i>in vivo</i>.</p><p><strong>Methods: </strong>The control group consisted of porous titanium root analogue implants fabricated via digital medical technology and 3D printing, while the experimental group included porous titanium root analogue implants with CSn and CSn-TAK242 bioactive coatings. Three groups of implants were inserted into the jaws of dogs, with their stability coefficients immediately measured upon implantation. After 3 months, samples were collected, and the bone integration and gingival attachment of the three groups were assessed using X-rays, Micro-CT, and histological section staining.</p><p><strong>Results: </strong>All groups of porous titanium root analogue implants were correctly placed within the alveolar sockets. The stability coefficients of the implants immediately post-implantation in the control group, CSn group, and CSn-TAK242 group were (64.29 ± 4.01), (62.55 ± 1.98), and (64.59 ± 3.28), respectively, with no significant statistical difference (P>0.05). Three months post-surgery, imaging and histological examinations revealed bone integration with the surrounding bone tissue for all implant groups. BIC results showed: control group (68.11 ± 3.63)%, CSn group (71.07 ± 2.83)%, and Csn-TAK242 group (78.6 ± 4.52)%, with the BIC being highest in the CSn-TAK242 group, followed by the CSn group, and lowest in the control group (P<0.05). More importantly, compared with the control group, the BV/TV of the CSn-TAK242 group was significantly higher. In addition, the Tb.Th of the CSn-TAK242 group was significantly higher than that of the control group and CSn group (P<0.05). The smooth structures at the upper ends of the implants had tight gingival tissue attachment.</p><p><strong>Conclusion: </strong>Porous titanium root analogue implants consistent with the target root morphology were successfully fabricated using digital medical technology and 3D printing. The composite CSn-TAK242 coating further enhanced the osseointegration effects of these implants.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1673758"},"PeriodicalIF":4.8000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531250/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1673758","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Chitosan nanoparticles loaded with TLR4 inhibitors (TAK242) were coated on porous titanium root analogue implants and placeded into beagles to investigate the role of TLR4 inhibitors in inhibiting inflammatory reactions and promoting osseointegration in vivo.
Methods: The control group consisted of porous titanium root analogue implants fabricated via digital medical technology and 3D printing, while the experimental group included porous titanium root analogue implants with CSn and CSn-TAK242 bioactive coatings. Three groups of implants were inserted into the jaws of dogs, with their stability coefficients immediately measured upon implantation. After 3 months, samples were collected, and the bone integration and gingival attachment of the three groups were assessed using X-rays, Micro-CT, and histological section staining.
Results: All groups of porous titanium root analogue implants were correctly placed within the alveolar sockets. The stability coefficients of the implants immediately post-implantation in the control group, CSn group, and CSn-TAK242 group were (64.29 ± 4.01), (62.55 ± 1.98), and (64.59 ± 3.28), respectively, with no significant statistical difference (P>0.05). Three months post-surgery, imaging and histological examinations revealed bone integration with the surrounding bone tissue for all implant groups. BIC results showed: control group (68.11 ± 3.63)%, CSn group (71.07 ± 2.83)%, and Csn-TAK242 group (78.6 ± 4.52)%, with the BIC being highest in the CSn-TAK242 group, followed by the CSn group, and lowest in the control group (P<0.05). More importantly, compared with the control group, the BV/TV of the CSn-TAK242 group was significantly higher. In addition, the Tb.Th of the CSn-TAK242 group was significantly higher than that of the control group and CSn group (P<0.05). The smooth structures at the upper ends of the implants had tight gingival tissue attachment.
Conclusion: Porous titanium root analogue implants consistent with the target root morphology were successfully fabricated using digital medical technology and 3D printing. The composite CSn-TAK242 coating further enhanced the osseointegration effects of these implants.
期刊介绍：
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
